[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE289804T1 - Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten - Google Patents

Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten

Info

Publication number
ATE289804T1
ATE289804T1 AT99951810T AT99951810T ATE289804T1 AT E289804 T1 ATE289804 T1 AT E289804T1 AT 99951810 T AT99951810 T AT 99951810T AT 99951810 T AT99951810 T AT 99951810T AT E289804 T1 ATE289804 T1 AT E289804T1
Authority
AT
Austria
Prior art keywords
chlorite
hydrogen peroxide
ophtahalmological
dermatological
preparations
Prior art date
Application number
AT99951810T
Other languages
English (en)
Inventor
Hampar L Karagoezian
Original Assignee
Hampar L Karagoezian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampar L Karagoezian filed Critical Hampar L Karagoezian
Application granted granted Critical
Publication of ATE289804T1 publication Critical patent/ATE289804T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/20Elemental chlorine; Inorganic compounds releasing chlorine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/13Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
AT99951810T 1998-10-08 1999-10-06 Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten ATE289804T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16962098A 1998-10-08 1998-10-08
PCT/US1999/023291 WO2000019981A1 (en) 1998-10-08 1999-10-06 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide

Publications (1)

Publication Number Publication Date
ATE289804T1 true ATE289804T1 (de) 2005-03-15

Family

ID=22616449

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951810T ATE289804T1 (de) 1998-10-08 1999-10-06 Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten

Country Status (6)

Country Link
US (2) US6488965B1 (de)
EP (1) EP1119347B1 (de)
AT (1) ATE289804T1 (de)
AU (1) AU6416999A (de)
DE (1) DE69923987T2 (de)
WO (1) WO2000019981A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US20070104798A1 (en) 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
MXPA02012206A (es) * 2000-07-14 2003-06-04 Allergan Inc Composiciones que contienen componentes terapeuticamente activos que tienen solubilidad mejorada.
CA2402405C (en) 2000-07-14 2008-02-12 Allergan Sales, Inc. Compositions containing alpha-2-adrenergic agonist components
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050177892A1 (en) * 2001-02-12 2005-08-11 Pioneer Hi-Bred International, Inc. Maize Rar1-interactor polynucleotides and methods of use
PE20030263A1 (es) * 2001-07-31 2003-04-17 Novartis Ag Composicion farmaceutica oftalmica
CA2462871C (en) * 2001-10-05 2013-07-02 Steris Inc. In vitro model for priocidal activity
KR100444893B1 (ko) * 2001-12-24 2004-08-21 주식회사 화이투스 치약 조성물
AU2003233445A1 (en) * 2002-03-27 2003-10-13 William O. Kling Antimicrobial compositions and methods of use
JP4244129B2 (ja) * 2002-10-28 2009-03-25 株式会社メニコン 消毒方法
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US7087190B2 (en) * 2003-03-20 2006-08-08 Ecolab Inc. Composition for the production of chlorine dioxide using non-iodo interhalides or polyhalides and methods of making and using the same
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
US7071152B2 (en) * 2003-05-30 2006-07-04 Steris Inc. Cleaning and decontamination formula for surfaces contaminated with prion-infected material
JP4860475B2 (ja) * 2003-06-13 2012-01-25 アルコン,インコーポレイテッド 2種のポリマーの相乗作用的組み合わせを含む眼科用組成物
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7477940B2 (en) * 2003-06-30 2009-01-13 J&J Consumer Companies, Inc. Methods of administering an active agent to a human barrier membrane with galvanic generated electricity
US7480530B2 (en) 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US7476222B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
US7477938B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Cosumer Companies, Inc. Device for delivery of active agents to barrier membranes
US7477941B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of exfoliating the skin with electricity
US7479133B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Methods of treating acne and rosacea with galvanic generated electricity
US7477939B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of treating a wound with galvanic generated electricity
US7486989B2 (en) * 2003-06-30 2009-02-03 Johnson & Johnson Consumer Companies, Inc. Device for delivery of oxidizing agents to barrier membranes
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20040265395A1 (en) * 2003-06-30 2004-12-30 Ying Sun Device for delivery of reducing agents to barrier membranes
US7507228B2 (en) * 2003-06-30 2009-03-24 Johnson & Johnson Consumer Companies, Inc. Device containing a light emitting diode for treatment of barrier membranes
US8257780B2 (en) * 2003-10-31 2012-09-04 Resource Development L.L.C. Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using
US6994890B2 (en) * 2003-10-31 2006-02-07 Resource Development L.L.C. Cleaning and multifunctional coating composition containing an organosilane quaternary compound and hydrogen peroxide
DE602004025264D1 (de) * 2003-11-05 2010-03-11 Johnson & Johnson Vision Care Methoden zur vermeidung des klebens von linsen an ihren verpackungen
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
JP5112872B2 (ja) * 2004-10-07 2013-01-09 エヌジーイーエヌ・ファーマソーティカルズ・エヌ.ブイ. 創傷および火傷を治療するための組成物
CN103933614B (zh) 2005-02-14 2016-03-02 庄臣及庄臣视力保护公司 舒适的眼用器件及其制造方法
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
CA2634915A1 (en) 2005-12-22 2007-07-05 Taiji Biomedical, Inc. Chlorite formulations, and methods of preparation and use thereof
US9052529B2 (en) 2006-02-10 2015-06-09 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
US20070238630A1 (en) * 2006-03-29 2007-10-11 Phillips Douglas H Subcutaneous skin cleanser
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
US8150525B2 (en) 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US20100284951A1 (en) * 2009-05-07 2010-11-11 Thavisith Pongprapansiri Novel compositions for the treatment of wounds and skin care
WO2011059915A1 (en) 2009-11-13 2011-05-19 Johnson & Johnson Consumer Companies, Inc. Galvanic skin treatment device
CN102612378B (zh) * 2009-11-17 2014-11-26 诺华股份有限公司 用于接触透镜清毒的过氧化氢溶液和套件
US8735618B2 (en) 2010-05-07 2014-05-27 Resource Development L.L.C. Solvent-free organosilane quaternary ammonium compositions, method of making and use
RU2014130080A (ru) * 2011-12-22 2016-02-10 Нуво Рисерч Гмбх Липосомальные композиции хлоритов или хлоратов
CH710357A1 (de) * 2014-11-11 2016-05-13 Bogaert Jean-Pierre Kosmetisches und pharmazeutisches Mittel zur Behandlung von Hautrissen.
WO2016135219A1 (en) 2015-02-26 2016-09-01 Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol Topical composition for the treatment of mucosal lesions
US10835584B2 (en) 2016-06-17 2020-11-17 Nuvothera, Inc. Systems for treating dermal inflammatory conditions
WO2018019881A1 (en) * 2016-07-27 2018-02-01 Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol Bioadhesive platform to perform bioactive treatment
WO2018108256A1 (en) 2016-12-13 2018-06-21 Stahl Kurt Wilhelm Composition for dressing cutaneous lesions and manufacturing method thereof
US11096958B2 (en) 2018-04-27 2021-08-24 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
DE102019101434A1 (de) * 2019-01-21 2020-07-23 Hager & Werken Gmbh & Co Kg Zusammensetzung zur Behandlung oder Prävention von Infektionen und Entzündungen
CN112057351B (zh) * 2020-09-22 2023-01-24 西安诗莱梦特生物科技有限公司 透明质酸-羟丙基甲基纤维素复合水凝胶及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR959544A (de) * 1947-02-01 1950-03-31
US3082146A (en) * 1959-02-04 1963-03-19 Chemical Res Lab Of America In Process for the treatment of water
US3585147A (en) * 1969-10-01 1971-06-15 Int Dioxcide Inc Stabilized chlorine dioxide solutions containing a chloride and processes of making and using same
US4317814A (en) * 1980-06-12 1982-03-02 Felipe Laso Preparation and method for treating burns
US4296102A (en) * 1980-06-12 1981-10-20 Felipe Laso Method of combating amebiasis in humans
US4670185A (en) * 1982-07-19 1987-06-02 Lion Corporation Aqueous vesicle dispersion having surface charge
US4574084A (en) * 1983-02-25 1986-03-04 Peter Berger Process for the preparation of a modified aqueous chlorite solution, the solution prepared by this process and the use thereof
US4891216A (en) * 1987-04-14 1990-01-02 Alcide Corporation Disinfecting compositions and methods therefor
US4880638A (en) * 1988-08-23 1989-11-14 Bioxy International, Ltd. Biocidal composition and method for disinfecting articles
US5078908A (en) * 1989-10-02 1992-01-07 Allergan, Inc. Methods for generating chlorine dioxide and compositions for disinfecting
JPH06206825A (ja) * 1992-12-11 1994-07-26 Nippon Rooshiyon Kk 白癬菌、湿疹等による皮膚病の治療剤及び 皮膚殺菌活性化剤
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US5855922A (en) * 1995-12-07 1999-01-05 Bio-Cide International, Inc. Antiseptic composition and process for prophylaxis and therapeutic treatment of dermal disorders

Also Published As

Publication number Publication date
AU6416999A (en) 2000-04-26
DE69923987T2 (de) 2006-11-02
WO2000019981A1 (en) 2000-04-13
EP1119347A4 (de) 2003-06-04
US20150056272A1 (en) 2015-02-26
US6488965B1 (en) 2002-12-03
EP1119347B1 (de) 2005-03-02
DE69923987D1 (de) 2005-04-07
EP1119347A1 (de) 2001-08-01

Similar Documents

Publication Publication Date Title
ATE289804T1 (de) Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten
US8632823B2 (en) Treatment of infected tissues with hypochlorous acid
JP5816406B2 (ja) 酸化還元電位水溶液を使用する皮膚潰瘍の治療方法
US5855922A (en) Antiseptic composition and process for prophylaxis and therapeutic treatment of dermal disorders
Sebben Surgical antiseptics
EP1787650A3 (de) Therapeutische Zusammensetzung mit einer quaternären Organosilanverbindung und Wasserstoffperoxid für die Behandlung von Hautproblemen
WO2006040688B1 (en) Inhibitors of acetylcholinesterase for treating skin diseases
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
AU2002322298A1 (en) Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
DE69832710D1 (de) Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
Brown et al. A review of topical agents for wounds and methods of wounding: guidelines for wound management
EP2533776A1 (de) Dermatologische zusammensetzung mit einer kombination aus adapalen und beonzoylperoxid zur behandlung von akne bei der nichtkaukasischen bevölkerung mit verminderter postinflammatorischer hyperpigmentierung
WO2002074290B1 (en) Dermatological preparations containing a nsaid
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ES2127613T3 (es) Utilizacion de un antagonista de tnf-alfa para el tratamiento de rojeces cutaneas de origen neurogeno.
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
US20190125790A1 (en) Use of hypochlorous acid as a topical antimicrobial
ES451188A1 (es) Un procedimiento para la preparacion de nuevas poliaminas.
CA2404210A1 (en) Pharmaceutical gel composition
Scanlon et al. To use or not to use? The debate on the use of antiseptics in wound care
Michael Harnessing the Antimicrobial Properties of Aloe Barbadensis Leaf Juice for Acne Skincare Publication date: Oct, 2024
Natarelli et al. Hypochlorous Acid: Applications in Dermatology
Hoon et al. Antimicrobial activity comparison of pure hypochlorous acid (0.01%)∗ with other wound and skin cleansers at nontoxic concentrations
MX2021003762A (es) Composiciones para limpieza y desinfeccion con propiedades cicatrizantes.
US7371367B2 (en) Method of treating inflammatory acne vulgaris and rosacea with carbamide peroxide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties